Prenatal Therapy in Congenital Adrenal Hyperplasia Attempted Prevention of Abnormal External Genital Masculinization by Pharmacologic Suppression of the Fetal Adrenal Gland in Utero
暂无分享,去创建一个
[1] G. Chrousos,et al. Pharmacologic suppression of the fetal adrenal gland in utero. Attempted prevention of abnormal external genital masculinization in suspected congenital adrenal hyperplasia. , 1985, JAMA.
[2] M. Novy,et al. Dexamethasone and estradiol treatment in pregnant rhesus macaques: effects on gestational length, maternal plasma hormones, and fetal growth. , 1983, American journal of obstetrics and gynecology.
[3] M. New,et al. A pilot newborn screening for congenital adrenal hyperplasia in Alaska. , 1982, The Journal of clinical endocrinology and metabolism.
[4] M. New,et al. Complement C4 allotypes in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: further evidence for different allelic variants at the 21-hydroxylase locus. , 1982, Clinical immunology and immunopathology.
[5] A. Goldman,et al. An H-2 linked difference in the binding of dexamethasone to murine hepatic cytosol receptor. A possible role of endogenous modifier(s). , 1981, Biochimica et biophysica acta.
[6] M. Forest,et al. Prenatal diagnosis of congenital adrenal hyperplasia (CAH) due to 21‐hydroxylase deficiency by steroid analysis in the amniotic fluid of mid‐pregnancy: Comparison with HLA typing in 17 pregnancies at risk for CAH , 1981, Prenatal diagnosis.
[7] S. Oparil,et al. Diurnal patterns and regulation of cortisol secretion in pregnancy. , 1980, The Journal of clinical endocrinology and metabolism.
[8] Z. Rosenwaks,et al. The Attenuated Form of Congenital Adrenal Hyperplasia as an Allelic Form of 21-Hydroxylase Deficiency* , 1980 .
[9] J. Winter,et al. Adult-onset familial adrenal 21-hydroxylase deficiency. , 1980, The American journal of medicine.
[10] M. Novy,et al. In utero regulation of rhesus monkey fetal adrenals: effects of dexamethasone, adrenocorticotropin, thyrotropin-releasing hormone, prolactin, human chorionic gonadotropin, and alpha-melanocyte-stimulating hormone on fetal and maternal plasma steroids. , 1979, Endocrinology.
[11] I. Merkatz,et al. PRENATAL DIAGNOSIS OF CONGENITAL ADRENAL HYPERPLASIA (21-HYDROXYLASE DEFICIENCY) BY HLA TYPING , 1979, The Lancet.
[12] R. Resnik,et al. Fetal lung maturation and the antenatal use of glucocorticoids to prevent the respiratory distress syndrome. , 1979, Obstetrical & gynecological survey.
[13] J. D. Funkhouser,et al. Distribution of Dexamethasone between Mother and Fetus after Maternal Administration , 1978, Pediatric Research.
[14] F. Possmayer,et al. Dexamethasone treatment of the guinea pig fetus: its effects on the incorporation of 3H-thymidine into deoxyribonucleic acid. , 1977, American journal of obstetrics and gynecology.
[15] A. Fauci,et al. Glucocorticosteroid therapy: mechanisms of action and clinical considerations. , 1976, Annals of internal medicine.
[16] R. Kotas,et al. Reversible inhibition of lung cell number after glucocorticoid injection into fetal rabbits to enhance surfactant appearance. , 1974, Pediatrics.
[17] M. Pinsky,et al. Conversion of maternal cortisol to cortisone during placental transfer to the human fetus. , 1974, American journal of obstetrics and gynecology.
[18] Wellmann Kf,et al. Fine structural changes in the rabbit placenta induced by cortisone. , 1972 .
[19] W. Hamilton. Congenital adrenal hyperplasia: Inborn errors of cortisol and aldosterone synthesis , 1972 .
[20] E. Motoyama,et al. Effect of cortisol on the maturation of fetal rabbit lungs. , 1971, Pediatrics.
[21] D. Warrell,et al. Outcome for the foetus of mothers receiving prednisolone during pregnancy. , 1968, Lancet.
[22] C. Migeon,et al. Cortisol production rate. IV. Infants born of steroid-treated mothers and of diabetic mothers. Infants with trisomy syndrome and with anencephaly. , 1966, Pediatrics.
[23] O. Green. STEROID METABOLISM IN THE FETUS AND THE NEWBORN INFANT. , 1965, Pediatric clinics of North America.
[24] A. Bongiovanni. THE ADRENOGENITAL SYNDROME WITH DEFICIENCY OF 3β-HYDROXYSTEROID DEHYDROGENASE , 1962 .
[25] A. Bongiovanni,et al. Steroids during pregnancy and possible fetal consequences. , 1960, Fertility and sterility.
[26] J. V. Van Wyk,et al. Virilizing adrenal hyperplasia; a genetic and hormonal study. , 1956, The Journal of clinical investigation.
[27] A. Bongiovanni,et al. Congenital adrenal hyperplasia with hypertension: unusual steroid pattern in blood and urine. , 1955, The Journal of clinical endocrinology and metabolism.
[28] G. Chrousos,et al. Late-onset 21-hydroxylase deficiency is an allelic variant of congenital adrenal hyperplasia characterized by attenuated clinical expression and different HLA haplotype associations. , 1982, Hormone research.
[29] M. New,et al. An update of congenital adrenal hyperplasia. , 1981, Recent progress in hormone research.
[30] I. Merkatz,et al. Amniotic fluid concentrations of delta 5 and delta 4 steroids in fetuses with congenital adrenal hyperplasia due to 21 hydroxylase deficiency and in anencephalic fetuses. , 1980, The Journal of clinical endocrinology and metabolism.
[31] E. Werk,et al. Studies on dexamethasone metabolism in man: effect of diphenylhydantoin. , 1972, The Journal of clinical endocrinology and metabolism.